HEALTH360X.AI: accelerating access to medical breakthroughs at the point of care

The National Institute for Minority Health and Health Disparities awarded Accuhealth Technologies Incorporated a $311,977 project grant on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to implement and scale the Health360X clinical research platform service for decentralized, point-of-care clinical trials.

Accuhealth will develop Health360X as a two-phase effort. Phase I focuses on optimizing electronic health record integration to enable clinical trial access within existing EHR systems at community-based and small to mid-sized practices, supported by Yale. Phase II evaluates platform adoption, implementation, and effectiveness through a real-world therapeutic trial use case conducted across a network of community-based practices, supported by the Clinical Trials Access Collaborative (CTAC). The platform emphasizes privacy-first design, data provenance, transparent governance, and health data literacy to build trust with providers and patients, removing barriers to research participation based on practice size, geography, or prior research ecosystem exposure.

Performance of work occurs in Atlanta, Georgia. The period of performance runs from September 1, 2026, through April 30, 2029. This is a Small Business Innovation Research (SBIR) Fast Track award, a collaboration between Accuhealth, Yale, and CTAC designed to address research efficiency priorities in minority health and health disparities.

Abstract

Accelerating health research and medical breakthroughs are top priorities for the NIH, the FDA, the national academy of medicine, and the pharmaceutical research and manufacturers of america (PHRMA). The goal of this sbir fast track proposal is to implement and scale the HEALTH360X clinical research platform service for point of care decentralized clinical trials. The fast track proposal is a collaboration between accuhealth, yale and clinial trials access collaborative (CTAC) and will leverage our decades long experience working with community providers to implement innovative solutions to the research deficit participation. This model also emphasizes the importance of data provenance and transparent governance. Through privacy-first design and intentional efforts to promote health data literacy, health 360X fosters long-term trust with both providers and patients. The outcome is a sustainable, community-led approach to trial access that is no longer constrained by practice size, geography, or prior exposure to the research ecosystem. Aim 1. Aim 1 (phase I). EHR optimization for clinical trial access objective: enable access to clinical trials by integrating and optimizing the health 360X clinical research platform within existing EHR systems, aided by yale, at community-based and small to mid-sized practices. Aim 2. (phase II) evaluate platform impact in a real-world use case objective: assess the adoption, implementation, and effectiveness of health 360X tools in a therapeutic trial use case aided by CTAC's funding, conducted across a network of community- based practices. This fast-track sbir project will directly address nimhd and ncats priority on research efficiency by implementing or enhancing commercially viable platforms that meet community practices where they are to ensure access to cutting-edge clinical research and scientific innovation by all populations.